Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00647387 · ClinicalTrials.gov registry record · NA
Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study
A NA study of Ventricular Septal Defects, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 20
- Study locations
NCT00647387 is a NA study of Ventricular Septal Defects that has completed, run by Abbott Medical Devices. The registered enrollment target is 92 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT00647387, a NA study of Ventricular Septal Defects, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 20
- Study locations
Study Summary
The AMPLATZER Muscular VSD Occluder was approved by the US Food and Drug Administration (FDA) in September, 2007. This study is designed to further evaluate the safety and effectiveness in subjects implanted with the AMPLATZER Muscular VSD Occluder.
Conditions Studied
Interventions
- DEVICE Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder)
Study Locations (20)
California
- Children's Hospital Los Angeles (USC) - Los Angeles
- Cedars-Sinai Medical Center - Los Angeles
- Ronald Reagan UCLA Medical Center - Los Angeles
- Valley Children's Hospital - Madera
- Stanford University Medical Center - Palo Alto
- Rady Children's Hospital - San Diego
Florida
- Joe DiMaggio Children's Hospital - Hollywood
- Jackson Memorial Hospital - Miami
- Arnold Palmer Hospital - Orlando
- All Children's Hospital - St. Petersburg
Arizona
- St. Joseph Hospital and Medical Center - Phoenix
- Phoenix Children's Hospital - Phoenix
Georgia
- Children's Healthcare of Atlanta - Atlanta
- Augusta University - Augusta
Illinois
- University of Chicago Medical Center - Chicago
- Advocate Christ Medical Center - Oak Lawn
Colorado
- Children's Hospital of Colorado - Aurora
Connecticut
- Yale New Haven Hospital - New Haven
Delaware
- Nemours/Alfred I. duPont Hospital for Children - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2008-03 |
| Est. Completion | 2024-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00647387
The ClinicalTrials.gov registry entry for NCT00647387 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventricular Septal Defects appearing as the primary indexed condition, and to 1 intervention - of which Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder) is the first listed.
NCT00647387 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT00647387 about?
NCT00647387 is a clinical study titled "Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study". The AMPLATZER Muscular VSD Occluder was approved by the US Food and Drug Administration (FDA) in September, 2007. This study is designed to further evaluate the safety and effectiveness in subjects implanted with the AMPLATZER Muscular VSD Occluder.
What is the current status of trial NCT00647387?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2008-03. Estimated completion is 2024-02-23.
What conditions does trial NCT00647387 study?
This clinical trial studies the following conditions: Ventricular Septal Defects.
What interventions are being tested in trial NCT00647387?
The interventions under investigation include: Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder) (DEVICE).
Who is sponsoring clinical trial NCT00647387?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00647387 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.